Target intelligence / Profile preview

Bone hydroxyapatite matrix (HA (when referring specifically to hydroxyapatite; no universal abbreviation for the full matrix))

Target
HA (when referring specifically to hydroxyapatite; no universal abbreviation for the full matrix)
Molecular classification
Other (mineral-organic extracellular matrix), Inorganic-organic composite
01

Overview

The **bone hydroxyapatite matrix** is the core inorganic component of bone tissue, consisting primarily of nanocrystalline, carbonated, and calcium-deficient hydroxyapatite (chemical formula Ca₁₀(PO₄)₆(OH)₂) integrated within an organic collagen type I network[1][2][3][4][5][6]. This composite provides both rigidity and elasticity to bone, allowing it to maintain structural support and participate in mineral metabolism. In vivo, bone hydroxyapatite is not pure stoichiometric hydroxyapatite, but rather a structurally imperfect form with carbonate and other substitutions, and an amorphous surface layer rich in hydrogen phosphate ions[3][5]. It is not itself a drug target but is fundamental to bone biology and the site of action for several bone-modifying agents (e.g., bisphosphonates) that adsorb to the mineral and affect bone cell interactions. Variations or defects in the hydroxyapatite matrix contribute to various skeletal diseases and pathological calcifications[6][7]. "Bone hydroxyapatite matrix" is not a standard designation for a druggable target (e.g., receptor, transporter, channel). Hydroxyapatite is a **mineral** not a protein, receptor, or classic molecular target; the matrix is the combined framework of hydroxyapatite and organic components, mainly type I collagen[2][6]. The matrix's major role is biomechanical, not as a signaling receptor or as an enzyme. This is not a drug target by standard definitions. "Bone hydroxyapatite matrix" describes an extracellular structure, not a receptor or molecular entity typically targeted by therapeutics. The term is scientifically accurate but may be too broad or imprecise as a "target" entry for therapeutic drug discovery.

Other names
HydroxyapatiteBone mineralHAHApBone apatiteCarbonated hydroxyapatite
02

Mechanism of action

None (Matrix is not a drug target. Some drugs affect hydroxyapatite indirectly, e.g., bisphosphonates bind to bone mineral to inhibit resorption.)

03

Biological functions

Mechanical support of boneStorage of calcium and phosphateStructural framework for bone cells
04

Disease associations

Other (not a traditional therapeutic target, but changes implicated in diseases: osteoporosis, bone fragility, skeletal dysplasias, bone metastases)Pathological calcification (e.g., soft tissue calcification, tumors)
05

Safety considerations

Abnormal mineralization (calcification pathology)Brittle bone from aberrant matrix composition/remodeling
06

Interacting drugs

None (Not a direct therapeutic target; no classic small-molecule, antibody, or therapeutic drugs directly targeting the matrix. However, therapies may target bone remodeling.)
07

Biomarkers

Bone mineral density (BMD)Hydroxyapatite crystal composition (in research/diagnostics)Calcium and phosphate metabolism parameters (indirect markers)

Beyond the preview

Go deeper on Bone hydroxyapatite matrix (HA (when referring specifically to hydroxyapatite; no universal abbreviation for the full matrix)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bone hydroxyapatite matrix (HA (when referring specifically to hydroxyapatite; no universal abbreviation for the full matrix)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call